ENVISIA THERAPEUTICS TO PRESENT AT AMERICAN GLAUCOMA SOCIETY 2017 ANNUAL MEETING

ENVISIA THERAPEUTICS TO PRESENT AT AMERICAN GLAUCOMA SOCIETY 2017 ANNUAL MEETING

Company to Present at the Largest Gathering of US Glaucoma Specialists

RESEARCH TRIANGLE PARK, NC March 2, 2017 – Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology, today announced that it will present a podium presentation and two posters at the American Glaucoma Society (AGS) Annual Meeting being held March 2-6, 2017 in San Diego, CA. Read more here.

Copyright 2013 Envisia Therapeutics